Dinner Symposium with CME Provided
Sunday, April 27, 2025
4:00 pm - 5:30 pm
Hilton Hawaiian Village: Coral II (Mid-Pacific Conference Center)
Ensuring safe medication practices to prevent errors and protect patients from harm is an ongoing endeavor. For nearly three decades, the Institute for Safe Medication Practices (ISMP) has been drawing attention to errors and adverse events associated with parenteral nutrition (PN). Persistent shortages of PN products have exacerbated the risk of errors in the prescribing, preparing, and administering of these sterile compounds.
Lipid injectable emulsions (ILEs) are complex pharmaceutical formulations used as a source of energy and essential fatty acids in parenteral nutrition therapy. The use of alternative ILEs in neonatal and pediatric patients can provide clinical benefits by delivering necessary calories and nutrients.
Please join our panel of speakers as they review the risks and error prevention strategies associated with the prescribing, preparation, and administration of parenteral nutrition as well as describe prescribing considerations and recommendations for use of alternative ILEs in neonatal and pediatric patients.
Intended Audience
- Neonatologists
- Pediatric specialists
- Pediatric generalists
- Pediatric educators
- Pediatric academic researchers
Learning Objectives
- Describe three strategies to minimize errors with use of parenteral nutrition in neonates.
- Evaluate the safety of fish-oil based lipid emulsions in premature infants and neonates.
- Analyze data supporting the use of alternative lipid emulsions in premature infants and neonates.
Interested in attending? Let us know.
Speakers
Rita Jew, PharmD, MBA, BCPPS, FASHP, President, ISMP
Katherine M. Ottolini, M.D., Assistant Professor of Pediatrics, George Washington University School of Medicine and Health Sciences Attending Neonatologist, Children’s National Hospital
Muralidhar Premkumar, M.B.B.S., D.C.H., D.N.B., Assistant Professor Baylor College of Medicine
CE Accreditation
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Institute for Safe Medication Practices. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy Continuing Education
Partners designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(Universal Activity Number - TBD)
Type of Activity: Knowledge
Funding Source: This activity is supported by Fresenius Kabi.
